A phase I trial of pegylated liposomal doxorubicin (PLD), carboplatin, bevacizumab, and veliparib (ABT-888) in recurrent, platinum-sensitive ovarian, primary peritoneal, and fallopian tube cancer: A Gynecologic Oncology Group study

• Published in: Gynecologic oncology Vol. 137; p. 23
• Main Authors: Brady, W.E, Armstrong, D.K, Moore, K.N, DiSilvestro, P.A, O'Malley, D.M, Tenney, M.E, Rose, P.G, Fracasso, P.M
• Format: Journal Article
• Language: English
• Published: Elsevier Inc 01.04.2015
• Subjects: Hematology, Oncology and Palliative Medicine; Obstetrics and Gynecology